JPMorgan Chase & Co’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-32
| Closed | -$57 | – | 6765 |
|
|
2025
Q1 | $57 | Buy |
32
+2
| +7% | +$4 | ﹤0.01% | 6088 |
|
|
2024
Q4 | $69 | Buy |
+30
| New | +$69 | ﹤0.01% | 6011 |
|
|
2022
Q2 | – | Sell |
-55
| Closed | -$1K | – | 5953 |
|
|
2022
Q1 | $1K | Buy |
+55
| New | +$1K | ﹤0.01% | 5667 |
|
|
2018
Q2 | – | Sell |
-54
| Closed | -$9K | – | 4866 |
|
|
2018
Q1 | $9K | Buy |
54
+12
| +29% | +$2K | ﹤0.01% | 4518 |
|
|
2017
Q4 | $9K | Buy |
+42
| New | +$9K | ﹤0.01% | 4506 |
|